About CG ONCOLOGY, INC.
CG Oncology is a biotechnology company focused on developing bladder-sparing immunotherapies for the treatment of non-muscle invasive bladder cancer (NMIBC). The company is committed to improving patient quality of life through innovative oncolytic immunotherapy research and clinical trials.
Is this your company?
Claim CG ONCOLOGY, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim CG ONCOLOGY, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.